scispace - formally typeset
S

Stephen V. Faraone

Researcher at State University of New York Upstate Medical University

Publications -  1470
Citations -  155368

Stephen V. Faraone is an academic researcher from State University of New York Upstate Medical University. The author has contributed to research in topics: Attention deficit hyperactivity disorder & Bipolar disorder. The author has an hindex of 188, co-authored 1427 publications receiving 140298 citations. Previous affiliations of Stephen V. Faraone include University of Bergen & National Institute for Health Research.

Papers
More filters
Journal ArticleDOI

A high-density single-nucleotide polymorphism screen of 23 candidate genes in attention deficit hyperactivity disorder: suggesting multiple susceptibility genes among Chinese Han population.

TL;DR: This study has identified several genes as promising susceptibility loci for ADHD and performed a comprehensive association analysis by screening with 245 single-nucleotide polymorphisms of 23 candidate genes in a sample of Chinese Han descent.
Journal ArticleDOI

Functional magnetic resonance imaging during auditory verbal working memory in nonpsychotic relatives of persons with schizophrenia: a pilot study

TL;DR: This pilot study suggests that relatives of persons with schizophrenia have subtle differences in brain function in the absence of psychosis, which add to the growing literature identifying neurobiological vulnerabilities to schizophrenia.
Journal ArticleDOI

The CBCL as a screen for psychiatric comorbidity in paediatric patients with ADHD

TL;DR: The utility of the CBCL as a screening tool for the identification of psychiatric comorbidity in ADHD youth in the primary care setting is supported, and good convergence between structured interview diagnoses and syndrome congruent CBCL scales is observed.
Journal ArticleDOI

Pharmacologic Treatments for Pediatric Bipolar Disorder: A Review and Meta-Analysis

TL;DR: More work is needed to assess the safety and efficacy of psychotropic drugs in children younger than 10 years, to further evaluation the efficacy of naturopathic compounds, and to further evaluate the effects of antimanic treatments for the management of depression and attention-deficit/hyperactivity disorder.